- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 163.46M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $200.76M |
| Stock Repurchased | Q1 2025 · Mar 7, 2024 | $191.6M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $842.42M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $908.73M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $67.35M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $0 |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $248.21M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $164.02M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.33B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.28B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.02B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.03B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.37B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.33B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $282.44M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $296.47M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 186.79M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $51.84M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$41.13M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.14B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.37B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.09 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $21.27M |
| Net Income | Q1 2025 · Mar 31, 2024 | $16.49M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$32.43M |
| Revenue | Q1 2025 · Mar 31, 2024 | $48.68M |